Stereotaxis Changes Date of First Quarter 2013 Conference Call to May 13, 2013
ST. LOUIS, April 24, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced it has changed the date of its conference call to discuss its 2013 First Quarter financial results to Monday, May 13, 2013 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company's results and corporate developments. The details of the call are as follows:
Stereotaxis to Report First Quarter 2013 Financial Results on May 2, 2013
ST. LOUIS, April 22, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2013 first quarter ended March 31, 2013 on Thursday, May 2, 2013 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company's results and corporate developments.
Stereotaxis Receives Regulatory Approval of Niobe(R) Technology in Japan; Begins Commercialization Efforts
ST. LOUIS, March 25, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has received regulatory approval of its Niobe® remote magnetic technology for cardiac ablations in Japan, a critical milestone in securing full market entry into the country. This approval allows the Company to begin marketing efforts, including establishing a local business infrastructure with in-country distributors, while working on obtaining reimbursement approval for full market entry, or the ability to initiate sales. Reimbursement approval is expected by the end of 2013.
Stereotaxis CEO Michael Kaminski Steps Down; Board Chairman William Mills III to Serve as Interim CEO
ST. LOUIS, March 5, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that Michael Kaminski will step down as President and Chief Executive Officer, effective April 12, 2013, to accept a position as division president of a company in an unrelated field. The Stereotaxis Board has appointed Chairman William Mills III as interim CEO and created an interim Office of the Chief Executive, with Director Dr. Euan Thomson providing support and guidance in certain areas to ensure a seamless transition to new company leadership. Augmenting this office will be a senior executive committee representing the Company's business segments. The Board will immediately retain an executive search firm to assist in conducting a comprehensive search for a successor.
Stereotaxis CFO Steps Down to Pursue New Career Opportunity
ST. LOUIS, Feb. 7, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) has announced that Sam Duggan, Chief Financial Officer, will resign from the Company, effective February 22, 2013. Serving as Stereotaxis CFO since October 2011, Mr. Duggan is leaving to accept a CFO position with a large, privately held company headquartered in St. Louis. Martin Stammer, Vice President and Controller, will assume the role of Interim CFO.